Growth hormone in the tumor microenvironment

AUTOR(ES)

Chesnokova, Vera

FONTE

Arch. Endocrinol. Metab.

DATA DE PUBLICAÇÃO

10/01/2020

RESUMO

ABSTRACT Tumor development is a multistep process whereby local mechanisms enable somatic mutations during preneoplastic stages. Once a tumor develops, it becomes a complex organ composed of multiple cell types. Interactions between malignant and non-transformed cells and tissues create a tumor microenvironment (TME) comprising epithelial cancer cells, cancer stem cells, non-tumorous cells, stromal cells, immune-inflammatory cells, blood and lymphatic vascular network, and extracellular matrix. We review reports and present a hypothesis that postulates the involvement of growth hormone (GH) in field cancerization. We discuss GH contribution to TME, promoting epithelial-to-mesenchymal transition, accumulation of unrepaired DNA damage, tumor vascularity, and resistance to therapy. Arch Endocrinol Metab. 2019;63(6):568-75

Documentos Relacionados

• A Novel Organotypic Model Mimics the Tumor Microenvironment
• Melanoma: tumor microenvironment and new treatments
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
• Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
• Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions